Literature DB >> 12428082

Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance.

Scott A McKee1, David C Sane, Efthymios N Deliargyris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12428082

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  27 in total

1.  The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation.

Authors:  Burak Pamukcu; Huseyin Oflaz; Rezzan Deniz Acar; Sabahattin Umman; Nevres Koylan; Berrin Umman; Yilmaz Nisanci
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 2.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

Review 3.  Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.

Authors:  Marco Zimarino; Giulia Renda; Raffaele De Caterina
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.

Authors:  Cezary Watala; Justyna Pluta; Jacek Golanski; Marcin Rozalski; Malgorzata Czyz; Zygmunt Trojanowski; Józef Drzewoski
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

5.  Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.

Authors:  Christopher N Floyd; Timothy Goodman; Silke Becker; Nan Chen; Agnesa Mustafa; Emma Schofield; James Campbell; Malcolm Ward; Pankaj Sharma; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

6.  Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease.

Authors:  Nauder Faraday; Lisa R Yanek; Dhananjay Vaidya; Brian Kral; Rehan Qayyum; J Enrique Herrera-Galeano; Taryn F Moy; Diane M Becker; Lewis C Becker
Journal:  Thromb Res       Date:  2009-01-30       Impact factor: 3.944

7.  Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

Authors:  Ibrahim Shah; Shakeel O Khan; Surender Malhotra; Tim Fischell
Journal:  Core Evid       Date:  2010-06-15

8.  Preoperative platelet response to collagen is associated with myocardial injury after off-pump coronary bypass graft in patients taking aspirin.

Authors:  Deok Man Hong; Yun Seok Jeon; Jun Hyun Kim; Tae Wan Lim; Young Jin Lim; Jae Hyon Bahk; Ki Bong Kim; Il Jae Kim
Journal:  Korean J Anesthesiol       Date:  2010-02-28

Review 9.  Genetic dissection of platelet function in health and disease using systems biology.

Authors:  Wadie F Bahou
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-09       Impact factor: 3.722

Review 10.  Patient-specific antiplatelet therapy.

Authors:  Ian D Conde; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.